Medicine guide

Tasigna 150 mg

As listed in the register: Tasigna 150 mg, harde capsules

150 mg · capsule, hard

  • Prescription only
  • Cancer treatments and immune-system medicines
Made by
Novartis Europharm Limited

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL01EA03

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byNovartis Europharm Limited
Active substanceNilotinib Hydrochloride 1-Water
Used inCancer treatments and immune-system medicines
Strength150 mg
Formcapsule, hard
ClassificationL01EA03 · Cancer treatments and immune-system medicines
Routeoraal gebruik
Dispensing (as stated by the register)Uitsluitend recept
Name in the registerTasigna 150 mg, harde capsules
RVGEU/1/07/422

Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician

Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.